(C) BRIMS 2010 Mass Spectrometry Unit MassachusettsThermo Fisher’s BRIMS-Strategy
under Testing

Coping with Customers’ Response to Divide and Conquer Tactics of Mass Spec-Manufacturers

July 2010. Divide customers and Conquer marketswon’t work any more to drive up sales, increase returns, or outbeat competitors in mass spectrometry. Research has been changing from vertical, in-house R&D to open innovation. Customers increasingly criticize mass spectrometry manufactures to misuse their market position or sell products with in-built barriers to swift data exchange among researchers across organisations. ThermoFisher set up BRIMS (Biomarker Research in Mass Spectrometry) in order to counter risks of scaring research customers away which they need to co-develop products, for example in the field of personalised cancer care.

Read about the unit, details of its staff, and criticisms of manufacturers as well as recommendations for improving mass spectrometers by experts from US Institute of Standards and Technology (NIST) or the NIH Cancer Proteomic Technologies Consortium. A divide and conquer approach won’t work anymore.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 7 pages
- Includes Market shares Europe by revenues, geographical region , and instrument segments.
Updated September 2013

Full Company License enquire here

Back to section

Related Editorial Articles

Handling Suppliers of Mass Spectrometers Delicately
Michael P. Myers, International Centre for Genetic Engineering and Biotechnology, Trieste (IT) tells how he is avoiding to get trapped by manufacturers of mass spectrometers and their strategies to fend off competitors with proprietary data formats. 

Electrophoresis in Proteomics
– Some Common Pitfalls and Smart Ways to Avoid Them

Instrument Standards: We need the users, and users have to adopt it
Oscar-Werner Reif, today global CSO and Member of Sartorius’ Group Executive Committee offers a global view on interconnectivity, quality, and harmonisation of standards for automation and devices

Laboratory Automation: Everyone re-invents the wheel
Michael Collasius, Vice President Automated Systems Qiagen NV, on industry-wide standards for laboratory instruments

TALEs, Zinc Fingers, or Meganucleases
A Practice View from Crop Research and Breeding

Diagnostic Microfluidics: Sample In – Results Out?
Marc Feiglin, former Chief Technology Officer Life Sciences at Tecan on strengths and weaknesses of electrowetting development, weaknesses of competitors like Illumina. Prospects of clinical microfluidics